SOV Therapeutics' Seed - II Round

SOV Therapeutics raised a round of funding on November 21, 2011.

SOV Therapeutics is a stealth company developing a method for modulating one or more side effects of reductase inhibitor therapy.…

Articles about SOV Therapeutics' Seed - II Round: